Phibro Animal Health Corporation
PAHC
$24.60
$0.100.41%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 347.83M | 309.26M | 260.43M | 273.16M | 263.22M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 347.83M | 309.26M | 260.43M | 273.16M | 263.22M |
| Cost of Revenue | 237.75M | 205.76M | 176.94M | 186.01M | 183.41M |
| Gross Profit | 110.08M | 103.50M | 83.50M | 87.15M | 79.81M |
| SG&A Expenses | 70.46M | 68.78M | 62.37M | 27.36M | 59.44M |
| Depreciation & Amortization | -- | -- | -- | 2.99M | -- |
| Other Operating Expenses | -- | -- | -- | 4.20M | -- |
| Total Operating Expenses | 308.21M | 274.54M | 239.31M | 249.75M | 242.85M |
| Operating Income | 39.61M | 34.73M | 21.12M | 23.41M | 20.37M |
| Income Before Tax | 29.69M | 4.84M | 9.62M | 6.41M | 12.92M |
| Income Tax Expenses | 8.81M | 1.65M | 2.65M | 5.66M | 4.52M |
| Earnings from Continuing Operations | 20.88M | 3.19M | 6.98M | 752.00K | 8.41M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 20.88M | 3.19M | 6.98M | 752.00K | 8.41M |
| EBIT | 39.61M | 34.73M | 21.12M | 23.41M | 20.37M |
| EBITDA | 52.23M | 46.30M | 30.13M | 31.18M | 29.57M |
| EPS Basic | 0.52 | 0.08 | 0.17 | 0.02 | 0.21 |
| Normalized Basic EPS | 0.55 | 0.22 | 0.20 | 0.18 | 0.21 |
| EPS Diluted | 0.51 | 0.08 | 0.17 | 0.02 | 0.21 |
| Normalized Diluted EPS | 0.55 | 0.22 | 0.20 | 0.18 | 0.21 |
| Average Basic Shares Outstanding | 40.52M | 40.50M | 40.50M | 40.50M | 40.50M |
| Average Diluted Shares Outstanding | 40.71M | 40.72M | 40.58M | 40.60M | 40.52M |
| Dividend Per Share | 0.12 | 0.12 | 0.12 | 0.12 | 0.12 |
| Payout Ratio | 23.30% | 152.59% | 69.68% | 646.41% | 57.82% |